Emami Ltd net profit plummets 28 percent in Q4

By

Maverick Martins

Published
May 4, 2018

FMCG major Emami Ltd reported nearly 28 percent fall in its consolidated net profit to Rs 60 crore (approx $ 9 million) for the quarter ended March 31, 2018 from Rs 83 crore (approx $ 12.5 million) for the year-ago period.
 

The company's revenue from operations witnessed 7 percent growth at Rs 617 crore (approx $ 92.5 million), as compared to Rs 576 crore (approx $ 86.2 million) during corresponding period of previous fiscal.
 
Emami’s international business grew 37 percent during the quarter with strong sales in the SAARC and MENAP regions. The company also made strategic investments in beauty start-ups like Brillare Science Pvt Ltd and The Man Company during the quarter.

Mohan Goenka, Director, Emami Limited in a statement said: “The year FY 17-18 has ended with a reasonably good Q4 registering a double digit growth of 12% on a Y-o-Y basis. Most of our brands have registered a good growth in this quarter. International business has also done well in this quarter by achieving a growth of 37%.”
 
Harsha V Agarwal, Director, Emami Limited said: “While Q4 witnessed a good growth led by Navratna, Pain Management and new launches, we expect the momentum to continue in FY19. With GST stabilisation, normal monsoon expectation coupled with higher government spending, FMCG is poised for a good growth. Strategic investment in upcoming growth segments through start-ups will help the company to grow further in years to come.”
 
Founded in 1974, Emami Limited is one of the leading personal and healthcare businesses in India, with a portfolio of over 300 products. It currently has operations in more than 60 countries including GCC, Europe, Africa, CIS countries and the SAARC.